India is now at the centre of a global health emergency caused by antibiotic-resistant infections, often called superbugs. A new study published in The Lancet highlights how fast these resistant bacteria are increasing and how gaps in treatment are putting millions of lives in danger. Doctors, researchers and public-health experts warn that the situation is worsening every year, and without strong action, many common infections may soon become difficult — or impossible — to treat.
The Lancet analysis reveals a shocking reality: in 2019, only 8% of bacterial infections in India that required the strongest “last-resort” antibiotics were actually treated correctly. This shows a massive mismatch between the need for life-saving medicines and the actual treatment people receive.
Surprisingly, India did not lack supply. The study notes that the country purchased nearly 80% of the complete antibiotic courses analysed. But despite this, most patients never received the right medicine at the right time. Many infections caused by carbapenem-resistant gram-negative (CRGN) bacteria — some of the hardest-to-treat superbugs — went untreated, even though the drugs existed in the system.
The consequences are deadly. In 2019 alone, drug-resistant bacterial infections killed an estimated 10.4 lakh (1.04 million) people in India. These numbers include a large portion of sepsis deaths, with about 33% linked directly to antimicrobial resistance. The situation shows how what were once manageable infections are now turning into life-threatening conditions.
India is more vulnerable to antibiotic resistance because of a combination of medical, environmental and behavioural factors. One of the biggest problems is easy access to antibiotics. Many people buy antibiotics without a prescription and use them without proper medical guidance. Some stop taking the medicine midway once they feel better, which allows bacteria to survive and become resistant. These habits turn antibiotics from life-saving drugs into tools that help bacteria evolve into stronger, more dangerous forms.
Another challenge is the uneven capacity of healthcare systems to detect resistant infections. Labs, hospitals and clinics across the country do not follow consistent testing methods. Without proper surveillance, many resistant infections go undetected or are misdiagnosed, meaning patients never receive the right treatment. This weak monitoring system also makes it difficult for health officials to understand how fast superbugs are spreading.
Environmental pollution also plays a major role. Waste from pharmaceutical factories, hospitals and households often contains antibiotic residues. When this waste enters rivers, lakes or sewage systems, it creates ideal conditions for bacteria to adapt and develop resistance. Over time, these resistant bacteria spread widely, entering the food chain and the community.
ALSO READ: New strategies aim to reshape global tech growth and future manufacturing
ALSO READ: Kejriwal’s swift ascent contrasts with Kishor’s early setback in debut political battles
Weak antibiotic-stewardship policies add to the crisis. Even when powerful antibiotics are available in hospitals, issues such as poor distribution, delays, stock handling problems or unclear guidelines prevent them from reaching the right patients. In many cases, doctors may prescribe antibiotics without knowing whether the infection is resistant or not, or they may choose less effective drugs because lab results take too long.
These factors together create a dangerous situation. Without rapid improvements, India risks entering a “post-antibiotic era” — a time when routine infections, simple surgeries, and common illnesses could once again become deadly. Lifesaving treatments in ICUs, cancer care, neonatal care and surgery depend heavily on effective antibiotics. Losing these medicines would put millions at risk and place immense pressure on hospitals.
Experts warn that the superbug crisis is no longer a future threat — it is happening now, and India must respond quickly and decisively.
To slow down the spread of resistant bacteria and protect public health, India needs strong, coordinated steps at every level of the healthcare system. The following actions are considered urgent and essential by researchers and policy experts:
Strengthen antimicrobial stewardship
Hospitals must ensure antibiotics are prescribed only when truly needed. Patients must also be educated to complete their full course of treatment instead of stopping early.
Improve nationwide surveillance
India needs more labs, better diagnostic tools and real-time reporting systems so that resistant infections can be detected quickly. This will help doctors choose the right medicines and allow the government to track patterns more effectively.
Regulate drug sales more strictly
Over-the-counter sale of antibiotics must be tightly controlled. Medicines should only be given with a valid prescription to prevent misuse and overuse.
Focus on prevention
Improved sanitation, clean water, regular vaccination, and strong infection-control practices in hospitals can significantly reduce the number of infections — which means fewer antibiotics will be needed.
Support research and innovation
India must invest in developing new antibiotics and exploring alternative treatments like phage therapy, immunotherapies, and improved diagnostic tools. As bacteria continue to evolve, medicine must evolve too.
The message from experts is clear: if India does not act now, the cost will be heavy. The fight against superbugs is not only about saving lives today — it is about protecting the future of modern medicine itself.
Copyright © © 2022 Copyright. All Rights Reserved with Arth Parkash